Scanadu, a Moffett Field, CA-based personalized health electronics company, raised $10.5m in Series A funding.
The round, which brought tht total amount raised to date to $14.7m, was led by Relay Ventures with participation from VegasTechFund, Ame Cloud Ventures, Broe Group, Mindful Investors and Redmile Group.
The company intends to use the funds for go-to market strategy and manufacturing, continue its path to FDA approval and hire people.
Led by founder and CEO Walter De Brouwer, Scanadu is developing the Scanadu ScoutTM, which is a vital sign monitor that analyzes, tracks and trends vitals – temperature, respiratory rate, oximetry, ECG, systolic blood pressure and diastolic blood pressure – in 10 seconds. The company is also creating a disposable urine analysis testing platform, ScanaFlo, which works with a smartphone to offer a complete urine analysis test in minutes. Once FDA approved, it could also measure for pregnancy complications, pre-eclampisa, gestational diabetes, heart-related kidney problems and urinary tract infections.
In July 2013, Scanadu closed a crowdfunding campaign on Indiegogo raising more than $1.6m (read here).